• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

AGS updates Web site

Article

The American Glaucoma Society (AGS) has updated its Web site at www.americanglaucomasociety.net.

San Francisco-The American Glaucoma Society (AGS) has updated its Web site at www.americanglaucomasociety.net.

The part of the site for the general public now includes up-to-date information about glaucoma and its treatment. An enhanced function allows patients to find society members practicing near them (non-member ophthalmologists will be able to apply for membership online).

New member-only features include enhanced annual meeting archives, online meeting registration and abstract submission capabilities, improved access to the Journal of Glaucoma, a video and multimedia resource center that soon will feature content from members, improved access to listserv (AGSNet) archives, listings of domestic glaucoma-related events and meetings, job listings, an enhanced “Find an AGS Member” function providing information not available to the public (for example, e-mail addresses), society-related news, and information about committees and their activities.

This fall, a new “AGS Forums” portion of the site will enable peer-to-peer discussions about clinical dilemmas, AGS business, billing questions, and other glaucoma-related matters. The software will be optimized for smartphones and tablet PCs and will allow the posting of all types of multimedia. AGS Forums eventually will replace AGSNet, but members who wish to continue to receive postings by e-mail will still be able to do so.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.